DR. MARK AMBROSE FONTANA, MD

Plain English
This study looked at the effects of a new treatment called coramitug for patients with transthyretin amyloid cardiomyopathy, a serious heart condition. Over 52 weeks, those given a higher dose of coramitug (60 mg/kg) had a significant 48% reduction in NT-proBNP levels, a marker of heart failure, compared to those who received a placebo. However, there was no meaningful difference in walking distance as measured by the 6-minute walk test between the groups. Who this helps: This research benefits patients suffering from transthyretin amyloid cardiomyopathy by offering a potential new treatment option.

Plain English
This study looked at how and when certain treatments for transthyretin amyloidosis with heart disease (ATTR-CM) improve survival rates. Researchers analyzed data from three major clinical trials and found that the benefit of these treatments, specifically TTR stabilizers and silencers, starts to show between 12 and 18 months after beginning therapy, with the survival benefit getting stronger over time. Notably, they estimate that the risk of mortality improves significantly by about 15 months after treatment starts, indicating that earlier intervention may be crucial for maximizing benefits. Who this helps: Patients with transthyretin amyloidosis and their doctors can better understand the importance of starting treatment early.

Plain English
Researchers focused on how to better track the progress of transthyretin amyloid cardiomyopathy (ATTR-CM), a heart condition caused by protein buildup. They reviewed data and updated recommendations for monitoring patients, suggesting specific measures to assess disease progression at regular intervals. This is important because early detection and monitoring can lead to better management of the disease, ultimately helping doctors tailor treatment more effectively. Who this helps: Patients with transthyretin amyloid cardiomyopathy.

Plain English
This study developed a new way to stage light chain (AL) amyloidosis, a serious illness affecting the heart, to better predict patient outcomes. Researchers included 2,493 patients and found that those classified as stage IIIC had a median survival of just 7 months, while survival for earlier stages increased significantly, with 1-year survival rates of 53% for stage IIIC and 68% for stage IIIB. This new staging system is important because it helps identify patients at the highest risk, allowing for more personalized and effective treatment plans. Who this helps: This helps patients and doctors by providing clearer guidance on patient prognosis and treatment strategies.

Plain English
This study looked at 1,087 patients with neurodevelopmental disorders (NDDs) to understand why some experience developmental regression, which means they lose skills they've previously learned. The researchers found that those who regressed had multiple variations in DNA repair genes, leading to increased sensitivity to DNA damage and a buildup of genetic changes related to their condition. This matters because it suggests that these genetic factors may play a significant role in how some individuals with NDDs deteriorate over time. Who this helps: This helps patients with neurodevelopmental disorders and their families.

Plain English
This study focused on ways to prevent kidney disease by building on a World Health Organization (WHO) resolution from 2025 that aims to tackle noncommunicable diseases. Researchers found that kidney disease is becoming a bigger health issue, similar to conditions like cancer and diabetes. They emphasize the importance of early detection and management of kidney health using five key factors: Albuminuria, Blood pressure, Cholesterol, Diabetes, and Estimated glomerular filtration rate (ABCDE), which could potentially improve overall health outcomes. Who this helps: This helps patients at risk of kidney disease and healthcare providers who treat them.

Plain English
This study looked at patients with aortic stenosis (narrowing of the heart's aortic valve) and transthyretin cardiac amyloidosis (a condition that affects the heart). It found that after five years, patients with both conditions had a higher risk of dying from any cause (75% more likely) compared to those with just aortic stenosis, although their risk of dying from heart problems specifically was similar. This is important because people with this combination of diseases may need closer monitoring and different treatment approaches to improve their health outcomes. Who this helps: Patients with aortic stenosis and cardiac amyloidosis.

Plain English
This study looked at how often fluid collections occur in patients after surgery to remove part of the pancreas. It found that nearly 50% of patients experience any fluid collection, while about 10% to 15% have collections that cause symptoms or require treatment. This matters because having a clear and consistent way to define these fluid collections can help doctors better compare results from different studies and improve patient care. Who this helps: This benefits patients and healthcare providers by improving treatment strategies after surgery.

Plain English
This study looked at how kidney diseases are becoming a major health issue, with chronic kidney disease expected to be a top cause of death by 2050. It found that Europe lacks effective treatments for kidney injuries and that the process for conducting clinical trials is complicated and discourages research, as there are challenges like patient diversity and stringent regulations. Improving the system for conducting these trials is crucial to developing new, life-saving treatments for kidney disease. Who this helps: This benefits patients with kidney disease and the doctors who treat them.

Plain English
This study looked at how well artificial intelligence (AI) can help doctors diagnose cardiac amyloidosis (CA) using echocardiograms, which are heart ultrasound images. They found that an AI method achieved an accuracy of 79.5% when distinguishing CA in the U.S. cohort, while a more advanced deep-learning model reached an impressive 96.2% accuracy in controlled settings. This improvement is significant since accurate diagnosis can lead to better treatment and management of CA, a condition that can be easily confused with other heart diseases. Who this helps: Patients with cardiac amyloidosis and their doctors will benefit from more accurate and efficient diagnoses.

Plain English
This study looks at two treatments for early childhood cavities: silver diamine fluoride (SDF) and atraumatic restorative treatment (ART). It will involve children aged 2-5 with cavities and assess how well each treatment stops the cavities from getting worse, how acceptable they are to families, and the overall quality of children's oral health over 6 and 12 months. About 234 teeth will be examined in each treatment group, and the results will help determine which method is better for managing early childhood caries. Who this helps: This benefits young children with tooth decay and their parents.

Plain English
This study focused on the best treatment options for patients with amyloid transthyretin cardiomyopathy (ATTR-CM), a condition that can cause heart failure. Researchers found that standard heart failure treatments need to be tailored for ATTR-CM patients due to their unique health challenges. While strategies like close monitoring and individualized medication can help reduce hospital visits, there’s still a lack of strong evidence for many common heart failure drugs in this specific group, highlighting the need for personalized care. Who this helps: This information benefits patients with ATTR-CM and their doctors by informing treatment decisions.

Plain English
This study examined patients with a heart condition called transthyretin amyloid cardiomyopathy (ATTR-CM) to see who might have a higher risk of stroke or mini-strokes (TIAs) even if their heart rhythm was normal. Out of 873 patients in normal rhythm, about 30.8% developed atrial fibrillation (AF) over about three years, and 9.7% had a stroke or TIA. Notably, patients with poor left atrial function had a much higher risk: those with very low contraction rates were ten times more likely to have a stroke compared to those with better heart function. Who this helps: This helps doctors in identifying high-risk ATTR-CM patients who may need closer monitoring or preventive treatment.

Plain English
This study looked at harmful particles in the air, specifically focusing on two different locations in Northern Italy during the summer of 2023 and winter of 2024. Researchers found that during winter, the levels of these particles were significantly higher, leading to much stronger negative effects on health, such as DNA damage and mutations, compared to summer. These findings are important because they emphasize the need to consider not just the amount of pollution, but also its harmful effects when assessing air quality, which can help in making better health policies. Who this helps: This helps patients, public health officials, and policymakers.

Plain English
This study looked at how to measure the progression of ATTR amyloid cardiomyopathy (ATTR-CM), a once-fatal heart condition. Researchers found that tracking specific signs, like worsening heart failure symptoms and changes in blood test results, can help doctors manage the disease better. With new treatments that can slow or even reverse the disease, understanding how to monitor its progression is crucial for improving patient care and overall quality of life. Who this helps: Patients with ATTR-CM and their healthcare providers.

Plain English
This study looked at the effects of a drug called acoramidis on patients with a serious heart condition known as transthyretin amyloid cardiomyopathy (ATTR-CM). Researchers found that 22.7% of patients taking acoramidis experienced significant health improvements over 30 months, compared to only 8.9% in the placebo group, meaning acoramidis can help improve heart function and overall health in these patients. This is important because it could change how we treat ATTR-CM from just managing the disease to actually helping patients feel better. Who this helps: This benefits patients with transthyretin amyloid cardiomyopathy.

Plain English
Researchers studied the use of proteomics, a technology that analyzes proteins, to improve the diagnosis of cardiac amyloidosis, a serious condition where misfolded proteins accumulate in the heart. They found that while proteomics is precise and can identify amyloid proteins effectively, its use is limited to specialized centers because it is complex and not standardized. Improving proteomics could lead to better diagnosis and treatment options for patients with this condition. Who this helps: This benefits patients with cardiac amyloidosis and their doctors.

Plain English
This study looked at how the drug sotatercept affects the heart in patients with pulmonary arterial hypertension (PAH), a serious lung condition. Researchers found that after about six months of treatment, patients showed significant improvements in their right heart function, including a 34 mL reduction in the size of the right ventricle and a 5% increase in how well the heart pumps blood. However, 28% of patients also developed new or larger fluid buildup around the heart, called pericardial effusion. Who this helps: This benefits patients with pulmonary arterial hypertension and their doctors by providing insights into the effects of sotatercept on heart function and potential side effects.

Plain English
The research study examined how well the drug vutrisiran works for improving health in patients with transthyretin amyloidosis and heart problems. They found that after 30 months, patients taking vutrisiran showed a median improvement of 3.8 points on a health questionnaire, particularly in areas like walking and feeling discouraged due to heart failure. This matters because better health can lead to a higher quality of life for these patients, and vutrisiran seems to make a significant difference, especially for younger patients. Who this helps: Patients with transthyretin amyloidosis and heart issues.

Plain English
This study examined hospitalizations of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) six months before they were diagnosed. Out of nearly 11,000 patients, 41.1% had at least one hospitalization before their ATTR-CM diagnosis, with women being 39% more likely to have had prior hospital visits. The most frequent reasons for these earlier hospitalizations were heart-related issues, and patients who had been hospitalized before faced double the risk of dying when eventually admitted for ATTR-CM. Who this helps: This research benefits patients, especially women and those with related heart conditions.

Plain English
This study looked at chronic spontaneous urticaria, a skin condition that causes itchy hives and has no cure, only treatments that can help manage symptoms. Researchers found that some current treatments are not very effective for many patients, and they explored a potential new avenue involving purinergic signaling—a process in the body related to inflammation. They noted that targeting a specific receptor, called P2X7, may lead to better treatment options for patients who don't respond well to existing therapies. Who this helps: This benefits patients with chronic urticaria, especially those who struggle to find relief with current treatments.

Plain English
This study focused on improving dental care by promoting a new approach called Minimum Intervention Oral Care (MIOC), which prioritizes prevention and preserving teeth rather than just performing procedures. The researchers, comprising 16 international experts, agreed on 14 recommendations to help implement this approach effectively, including better support for risk assessment and training for dental professionals. This is important because it aims to make oral health care more effective and accessible to everyone by shifting the focus to preventive care. Who this helps: This helps patients and dental care providers by promoting better oral health practices.

Plain English
This study looked at improving how doctors assess aortic stenosis, a condition where the heart's aortic valve narrows, using advanced computer models. Researchers created patient-specific models for five individuals and compared the results to real-life MRI data. They found that the models convincingly matched blood flow patterns, which helps doctors better understand the risks of blood clots forming in patients, ultimately leading to more personalized treatment strategies. Who this helps: This helps patients with aortic stenosis and their doctors in making more accurate treatment decisions.

Plain English
This study looked at how a specific type of catalyst, made from copper oxide and tin oxide, changes while it's being used to turn carbon dioxide (CO2) into carbon monoxide (CO), which has various industrial applications. Researchers used advanced imaging techniques during the chemical reactions to see how the catalyst's structure affects its performance. They found that understanding these changes can help create better catalysts for this process, which is important for reducing CO2 emissions and producing useful chemicals. Who this helps: This benefits researchers and companies working on cleaner energy technologies.

Plain English
This study looked at whether taking a small tissue sample (biopsy) during carpal tunnel surgery could help diagnose a heart condition called ATTR-CM earlier. Researchers found that 39% of patients had amyloid deposits, and among those tested, 28% showed signs of heart involvement, allowing many of them to start treatment sooner. Early diagnosis is crucial because it allows for therapy that can slow disease progression and improve patients' health outcomes. Who this helps: This research benefits patients with carpal tunnel syndrome who may also have underlying heart issues.

Plain English
This study focused on a heart condition called transthyretin amyloidosis (ATTR), specifically looking at how a measurement called extracellular volume (ECV) relates to heart health and survival rates. Researchers examined 1,541 patients and found that ECV could effectively predict the severity of myocardial amyloid deposits and related mortality risks: for every 10% increase in ECV, the risk of death rose by about 22%. This discovery matters because it provides doctors with a new way to assess and plan treatment for patients with ATTR, which can lead to better management of the disease. Who this helps: Patients with transthyretin amyloidosis and their doctors.

Plain English
This study focused on the effectiveness of a drug called acoramidis for treating a heart condition known as transthyretin amyloid cardiomyopathy (ATTR-CM), which can be either wild-type or variant. Results showed that after 30 months, acoramidis reduced the risk of death or cardiovascular-related hospitalizations by 31% in patients with wild-type ATTR-CM and by 59% in those with the variant form. This matters because these findings suggest that acoramidis can significantly improve outcomes for patients with this serious heart condition. Who this helps: Patients with transthyretin amyloid cardiomyopathy.

Plain English
This study looked at how physical activity affects the quality of life and nutritional health of patients who have just been diagnosed with cancer. Researchers found that patients who were more physically active reported better health-related quality of life, including improved emotional and social well-being, and experienced fewer symptoms like fatigue and pain. Specifically, those with higher activity levels showed significant improvements in their overall health status at the first nutritional assessment. Who this helps: This benefits newly diagnosed cancer patients by encouraging them to engage in physical activity for better health outcomes.

Plain English
This study looked at a specific type of particle decay called B_c^+→Dh^+h^-, which involves special subatomic particles known as mesons. For the first time, the researchers observed three decay processes and calculated their probabilities: B_c^+→D^+K^+π^− with a probability of about 0.00196, B_c^+→D^{*+}K^+π^− at about 0.00367, and B_c^+→D_{s}^{+}K^+K^− at about 0.00161. Understanding these decays is important because they provide new insights into the behavior of certain elementary particles and could help explain fundamental questions in physics, such as charge-parity violation. Who this helps: This helps physicists studying the fundamental properties of matter.

Plain English
Researchers studied a specific type of particle decay involving B mesons, which are fundamental particles. They found a significant violation of symmetry in these decays for the first time, with a CP asymmetry measured at 0.507 and a polarization fraction of 0.720. This discovery is important because it enhances our understanding of how certain particles behave, which can inform theories about matter and antimatter in the universe. Who this helps: This benefits physicists and researchers working on particle physics and the fundamental forces of nature.

Plain English
Researchers studied a rare decay process called B⁺→pΛ[over ¯] using data collected from proton-proton collisions at the Large Hadron Collider. They found that this decay happens with a rate of about 1.24 in 10 million decays, with a strong level of certainty in their results. Understanding this decay is important because it helps scientists learn more about the fundamental forces of nature and the behavior of matter. Who this helps: This benefits physicists and researchers studying particle physics.

Plain English
This study looked at specific types of particle decays called B mesons, focusing on how they transform into two baryons (particles made of three quarks) involving charm quarks. The researchers discovered a new decay process, B(s) to Λ(c)+ and Λ(c)- with high statistical significance (6.2 sigma), and they also found evidence of another decay, B0 to Λ(c)+ and Λ(c)- with a significance of 4.3 sigma. They calculated the probabilities for these decays to occur, which are about 0.0000101 for B0 and 0.0000050 for B(s), providing new information for scientists studying particle physics. Who this helps: This research benefits physicists and researchers working on particle physics and the fundamental forces of the universe.

Plain English
In 572 people with type 2 diabetes, cardiac MRI was used to measure both reduced blood flow reserve (a marker of silent ischemia) and evidence of prior heart attacks to see which better predicted future cardiovascular events. Having either abnormality raised the risk of a major cardiac event to about twice that of people with neither, and having both together tripled the risk. The finding supports combining these two measurements in routine cardiac imaging to identify which diabetic patients are at highest risk.

Plain English
This study looks at new types of actuators for space robots that work well in the vacuum of space. The researchers developed electrostatic actuators that can change size when electricity is applied, achieving forces over 4 Newtons and working at speeds greater than 100 times per second, while also being lightweight. This advancement is important because it offers a reliable and effective way to control robotic movements in space without the issues conventional methods face, like heat problems and lubrication challenges. Who this helps: This benefits engineers and designers working on robotics for space exploration.

Plain English
This study looked at different medications available for treating lower urinary tract symptoms (LUTS), which can cause discomfort and affect daily life. Researchers found that combining various types of medications can significantly improve patients' quality of life. This matters because finding the right treatment can help many people manage their symptoms better. Who this helps: Patients suffering from lower urinary tract symptoms.

Plain English
This study looked at how dentists in Egypt and Saudi Arabia diagnose and treat deep carious lesions (DCLs) in teeth. Out of 1,000 surveyed dentists, 500 responded, revealing that 23.2% of general practitioners, 34.2% of pediatric dentists, and 21.8% of endodontists preferred selective caries removal, a less invasive method. The findings highlight a gap in treatment choices, as many dentists still lean toward more invasive procedures despite guidelines that recommend conservative approaches for managing DCLs, emphasizing the need for better adherence to evidence-based practices. Who this helps: This helps patients by promoting less invasive dental treatments that can preserve tooth health.

Plain English
Researchers studied a new kind of particle called a "charmed baryon" using high-energy collisions between protons. They identified four different baryon states, with the most notable being the previously unobserved baryon called Ξ_{c}(2923)^{+}. This particle has a mass of about 2922.8 MeV and a decay width of about 5.3 MeV, which means they have measured its properties more accurately than before. These findings are important for improving our understanding of the fundamental building blocks of matter. Who this helps: This helps physicists and researchers studying particle physics.

Plain English
This study looked at how effective a blended learning course was for nurses in managing healthcare-associated infections in Ascoli Piceno, Italy. Out of 309 nurses surveyed, 222 responded, showing a 71.8% participation rate, and the results indicated that while nurses were eager to apply what they learned, issues like staff shortages made it difficult to implement new practices. Understanding these challenges is crucial for improving training programs and enhancing patient safety in healthcare settings. Who this helps: This helps nurses and healthcare facilities by improving training effectiveness and patient care.

Plain English
Researchers studied the properties of certain particles called B_{c}^{+} mesons using data from high-energy collisions at the Large Hadron Collider. They found a significant structure in the mass of these particles, which includes two closely spaced peaks at about 6705 MeV and 6752 MeV, confirming predictions about their excited states. This discovery is important because it helps scientists understand how these heavy particles behave and interact, which contributes to our knowledge of fundamental physics. Who this helps: This benefits physicists and researchers studying particle behavior and the fundamental forces of nature.

Plain English
This study looked at a specific decay process of a particle called B+ and measured how often it occurs compared to a similar decay. Researchers found that the rate of this decay is about 0.000000215, which is a very small number, and they also measured an asymmetry related to a property called CP symmetry, which was about 5.4%. This research is important because it helps scientists better understand the behaviors of particles and the forces at play in the universe. Who this helps: This helps physicists and researchers studying particle physics and the fundamental forces of nature.